Home>Topics>Companies>Synthes Holding AG

Synthes Holding AG

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
  1. New Morningstar Analyst Report for Johnson & Johnson

    Stock Reports

    Wed, 16 Apr 2014

    of orthopedic device firm Synthes , which was largely driven ..... valuation, as the price paid for Synthes largely accounts for incremental ..... deal. As J&J integrates Synthes , we will be able to gauge ..... to be value-accretive. Johnson & Johnson is the world's largest ..... expect patent losses and the Synthes acquisition to reduce this

  2. Johnson & Johnson Posts Solid 2Q, Buoyed by New Drug Launches and Return of Several OTC Products

    Commentary

    Tue, 16 Jul 2013

    Johnson & Johnson JNJ reported second-quarter results largely in line with our expectations ..... drag on this part of J&J's portfolio. Excluding the acquisition of Synthes and other portfolio changes, J&J's device segment was flat year

  3. Johnson & Johnson Looks To Get Ahead With Blocking And Tackling

    Headlines

    Tue, 22 Jan 2013

    By Stephen Simpson : With the Synthes acquisition done and Zytiga on the market, I don't think Johnson & Johnson ( JNJ ) investors should expect too much additional flash in 2013. That may not be such a bad thing, though, as this is a pretty

  4. J&J Posts Solid 4Q Results, but Offers Weak Outlook for 2013

    Commentary

    Tue, 22 Jan 2013

    inflection point for Johnson & Johnson , and we see the ..... device side, the Synthes acquisition not ..... from the recent Synthes acquisition, Johnson & Johnson posted 4% year ..... period, with the Synthes acquisition providing

  5. J&J Posts 3Q Results Slightly Shy of Our Expectations, but Strong Long-Term Outlook Intact

    Commentary

    Tue, 16 Oct 2012

    Johnson & Johnson JNJ reported third-quarter results slightly below our expectations ..... increased operationally 10.8% year over year as the recently completed Synthes acquisition added 5.8% to growth. This 5% underlying growth represented

  6. Mild Winter Decelerates Synthes Growth, J&J Offer Extended

    Commentary

    Wed, 25 Apr 2012

    Sates and Europe cut into Synthes ' SYST growth rate in recent months. In the first quarter, Synthes sales only grew 2% in local ..... that geographic region. Synthes also continues to expand ..... overshadowed by a mild winter, Synthes ' emerging market growth ..... intact. We still expect Johnson & Johnson JNJ to benefit from those

  7. Johnson & Johnson Picks Head of Devices Segment to Take Over for Retiring CEO

    Commentary

    Wed, 22 Feb 2012

    Johnson & Johnson JNJ announced William ..... the integration of Synthes , the device business ..... the group chairman of Johnson & Johnson 's pharmaceutical ..... Africa. He briefly left Johnson & Johnson to run Novartis' North

  8. Synthes Still Prepping for J&J Merger

    Commentary

    Thu, 16 Feb 2012

    fair value estimate for Synthes SYST after it reported solid ..... value estimate represents Johnson & Johnson 's JNJ current offer for Synthes . Also, with recent changes ..... fair value estimate for Synthes as well. Earlier this week

  9. Stryker Aiming for Double-Digit Earnings Growth in 2012 and Beyond

    Commentary

    Wed, 25 Jan 2012

    Stryker aims to level the playing field in this market that Synthes has long dominated. It may even benefit from any integration mishaps once Johnson & Johnson JNJ acquires Synthes . Overall, though, management remained cautious about the

  10. One-Time Charges Weigh on J&J's Otherwise In-Line 4Q

    Commentary

    Tue, 24 Jan 2012

    nonrecurring charges, Johnson & Johnson JNJ reported fourth ..... the fourth quarter, Johnson & Johnson posted operational ..... expect the addition of Synthes to significantly improve ..... weighed on sales. Synthes adds one of the fastest

« Prev12Next »
Content Partners